OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Yoon Sin Oh, Hee‐Sook Jun
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 26-26
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues
Estefanía Burgos‐Morón, Zaida Abad‐Jiménez, A Marañón, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 468

Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
Tianjiao Zhao, Wei Wu, Sui Li-hua, et al.
Bioactive Materials (2021) Vol. 7, pp. 47-72
Open Access | Times Cited: 216

Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review
Martina Rekatsina, Antonella Paladini, Alba Piroli, et al.
Advances in Therapy (2019) Vol. 37, Iss. 1, pp. 113-139
Open Access | Times Cited: 186

Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury
Lei Wang, Yan Liu, Xu Dong Zhang, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 79

Flavonoids: A treasure house of prospective pharmacological potentials
Hasin Hasnat, Suriya Akter Shompa, Mirazul Islam, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27533-e27533
Open Access | Times Cited: 68

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Fasiha Kanwal, Jennifer R. Kramer, Liang Li, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 11, pp. 1314-1314
Closed Access | Times Cited: 24

GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease
Kallirhoe Kalinderi, Vasileios Papaliagkas, Liana Fidani
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3812-3812
Open Access | Times Cited: 18

Recent Developments of Biomaterials for Additive Manufacturing of Bone Scaffolds
You Chen, Weilin Li, Chao Zhang, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 23
Closed Access | Times Cited: 114

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer’s and Parkinson’s disease therapeutics
Therese S. Salameh, Elizabeth M. Rhea, Konrad Talbot, et al.
Biochemical Pharmacology (2020) Vol. 180, pp. 114187-114187
Open Access | Times Cited: 106

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
HaEun Cho, Surabhi Shukla
Pharmaceuticals (2020) Vol. 14, Iss. 1, pp. 29-29
Open Access | Times Cited: 90

The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases
Aikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, et al.
Current Opinion in Pharmacology (2021) Vol. 62, pp. 85-96
Closed Access | Times Cited: 89

Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
Ji‐Xian Song, Ji‐Ren An, Qi Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 8334-8348
Open Access | Times Cited: 67

Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases
Manzar Alam, Sabeeha Ali, Sarfraz Ahmed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12162-12162
Open Access | Times Cited: 66

Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis
Johannes F.E. Mann, John B. Buse, Thomas Idorn, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 9, pp. 2058-2066
Open Access | Times Cited: 60

The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF
Coenraad Withaar, Laura M G Meems, Edgar E. Nollet, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 10, pp. 1298-1314
Open Access | Times Cited: 37

The Role of Oxidative Stress Enhanced by Adiposity in Cardiometabolic Diseases
Iwona Świątkiewicz, Marcin Wróblewski, Jarosław Nuszkiewicz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6382-6382
Open Access | Times Cited: 36

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33

Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
Aikaterini Andreadi, Saverio Muscoli, Rojin Tajmir, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1646-1646
Open Access | Times Cited: 27

Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists
Puja Ghosh, Rosaria Anna Fontanella, Lucia Scisciola, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4872-4884
Open Access | Times Cited: 25

Edaravone: A Novel Possible Drug for Cancer Treatment?
Elisa Duranti, Nicoletta Cordani, Chiara Villa
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1633-1633
Open Access | Times Cited: 8

Advancing chronic and acute wound healing with cold atmospheric plasma: cellular and molecular mechanisms, benefits, risks, and future directions
Nastaran Raissi-Dehkordi, Negar Raissi-Dehkordi, Hamed Ebrahimibagha, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1

Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
Habib Yaribeygi, Alexandra E. Butler, George E. Barreto, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2436-2446
Closed Access | Times Cited: 80

Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity
Habib Yaribeygi, Thozhukat Sathyapalan, Amirhossein Sahebkar
Life Sciences (2019) Vol. 234, pp. 116776-116776
Open Access | Times Cited: 70

GLP-1 mimetics and cognition
Habib Yaribeygi, Ali Rashidy‐Pour, Stephen L. Atkin, et al.
Life Sciences (2020) Vol. 264, pp. 118645-118645
Closed Access | Times Cited: 68

Page 1 - Next Page

Scroll to top